Device Trial Radar · NCT00686647
AngioSculpt® Coronary Bifurcation Study
Last checked: Nov 20, 2026Latest source record: Aug 10, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
93
Actual
Start
Apr 2008
Primary completion
Apr 2010
Study completion Jan 2011
Sponsor
- Lead sponsor
- AngioScore, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 30, 2008
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate a new angioplasty catheter, AngioSculpt® for the treatment of bifurcation lesions (blockages occurring at branch points) in coronary arteries.
Conditions
- Coronary Artery Disease
- Myocardial Ischemia
Interventions
AngioSculpt® Scoring Balloon CatheterDevice
Use of a stent for the main branch of a bifurcation lesion and use of a scoring balloon for the side branch of the same bifurcation lesion
AngioSculpt Scoring Balloon CatheterDevice
Treatment of the side-branch vessel of true bifurcation lesions using the AngioSculpt device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Procedural SuccessTime frame: 1 day
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Columbia University Medical Center
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.